Stock MTD METTLER-TOLEDO INTERNATIONAL, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Mettler-Toledo International, Inc.

Equities

MTD

US5926881054

Medical Equipment, Supplies & Distribution

Real-time Estimate Cboe BZX
Other stock markets
 11:29:19 2024-06-10 am EDT 		5-day change 1st Jan Change
1,432 USD -0.49% Intraday chart for Mettler-Toledo International, Inc. +2.28% +18.00%
Jun. 04 Mettler-Toledo International Inc. Enters into Amendment No. 7 Which Amended the Credit Agreement CI
May. 24 ANALYST RECOMMENDATIONS : Dollar General, Microchip Technology, Nvidia, Home Depot, Uber... Our Logo

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 19,320 27,118 39,011 32,225 26,302 30,724 - -
Enterprise Value (EV) 1 20,403 28,358 40,595 34,144 28,313 32,709 32,402 32,063
P/E ratio 35.3 x 45.8 x 51.8 x 37.6 x 33.8 x 37.9 x 33.6 x 29.3 x
Yield - - - - - - - -
Capitalization / Revenue 6.42 x 8.79 x 10.5 x 8.22 x 6.94 x 8.01 x 7.59 x 7.24 x
EV / Revenue 6.78 x 9.19 x 10.9 x 8.71 x 7.47 x 8.52 x 8 x 7.56 x
EV / EBITDA 25 x 32.1 x 36.8 x 27.6 x 23.6 x 26.5 x 24.3 x 22.5 x
EV / FCF 40,313,714 x 44,856,375 x 50,664,730 x 46,276,092 x 32,900,568 x - - -
FCF Yield 0% 0% 0% 0% 0% - - -
Price to Book 45.5 x 97.6 x 232 x 1,311 x -177 x -149 x -173 x -319 x
Nbr of stocks (in thousands) 24,354 23,795 22,986 22,294 21,684 21,357 - -
Reference price 2 793.3 1,140 1,697 1,445 1,213 1,439 1,439 1,439
Announcement Date 2/6/20 2/4/21 2/10/22 2/9/23 2/8/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 3,009 3,085 3,718 3,920 3,788 3,837 4,050 4,243
EBITDA 1 817.1 882.8 1,103 1,239 1,201 1,236 1,331 1,424
EBIT 1 778.1 840.7 1,058 1,192 1,152 1,173 1,262 1,331
Operating Margin 25.86% 27.25% 28.45% 30.42% 30.41% 30.56% 31.16% 31.37%
Earnings before Tax (EBT) 681.4 748.7 949.4 1,071 973.7 - - -
Net income 1 561.1 602.7 769 872.5 788.8 832 920.9 988
Net margin 18.65% 19.54% 20.68% 22.26% 20.82% 21.68% 22.74% 23.28%
EPS 2 22.47 24.91 32.78 38.41 35.90 37.92 42.82 49.10
Free Cash Flow 506.1 632.2 801.2 737.8 860.6 - - -
FCF margin 16.82% 20.49% 21.55% 18.82% 22.72% - - -
FCF Conversion (EBITDA) 61.94% 71.62% 72.66% 59.54% 71.66% - - -
FCF Conversion (Net income) 90.2% 104.89% 104.2% 84.56% 109.1% - - -
Dividend per Share 2 - - - - - - - -
Announcement Date 2/6/20 2/4/21 2/10/22 2/9/23 2/8/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales 1 1,037 897.8 978.4 985.8 1,058 928.7 982.1 942.5 935 925.9 930.7 962.1 1,016 955 986.4
EBITDA 1 330.6 253.1 296.9 318.8 370.4 278.5 319.9 308.2 294.3 279.8 284 321.4 352.1 305 318.4
EBIT 1 319.1 241.2 285.4 307.2 358.6 266.5 307.7 278 281.8 267.3 267.1 304.5 336 279.6 288.9
Operating Margin 30.76% 26.87% 29.17% 31.16% 33.91% 28.69% 31.33% 29.5% 30.14% 28.87% 28.7% 31.65% 33.06% 29.28% 29.29%
Earnings before Tax (EBT) - - - - - - - - - - - - - - -
Net income 1 230.9 174 212.1 220.6 265.8 188.4 213.9 201.6 184.8 177.5 184.5 228.1 231.8 - -
Net margin 22.26% 19.38% 21.68% 22.38% 25.13% 20.29% 21.78% 21.39% 19.76% 19.17% 19.82% 23.71% 22.81% - -
EPS 2 9.940 7.550 9.290 9.760 11.86 8.470 9.690 9.210 8.520 8.280 8.473 9.853 11.03 8.870 9.870
Dividend per Share 2 - - - - - - - - - - - - - - -
Announcement Date 2/10/22 5/5/22 7/28/22 11/3/22 2/9/23 5/4/23 7/27/23 11/9/23 2/8/24 5/9/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 1,083 1,240 1,583 1,919 2,011 1,985 1,677 1,339
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) 1.326 x 1.405 x 1.436 x 1.548 x 1.675 x 1.605 x 1.26 x 0.9398 x
Free Cash Flow 506 632 801 738 861 - - -
ROE (net income / shareholders' equity) 111% 171% 339% 889% - - - -
ROA (Net income/ Total Assets) 20.8% 21.5% 25% 25.6% 23% 25.1% 26.2% 27.5%
Assets 1 2,704 2,802 3,071 3,410 3,424 3,321 3,518 3,593
Book Value Per Share 2 17.40 11.70 7.310 1.100 -6.860 -9.640 -8.300 -4.510
Cash Flow per Share 2 24.20 29.90 38.70 37.80 44.00 44.50 47.40 54.90
Capex 1 97.3 92.5 108 121 105 122 106 106
Capex / Sales 3.24% 3% 2.89% 3.09% 2.78% 3.18% 2.62% 2.5%
Announcement Date 2/6/20 2/4/21 2/10/22 2/9/23 2/8/24 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Mettler-Toledo International, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
11
Last Close Price
1,439 USD
Average target price
1,319 USD
Spread / Average Target
-8.31%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

1st Jan change Capi.
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
+18.60% 30.72B
ABBOTT LABORATORIES Stock Abbott Laboratories
-2.26% 187B
MEDTRONIC PLC Stock Medtronic plc
+2.05% 110B
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-1.31% 69.54B
CENCORA, INC. Stock Cencora, Inc.
+14.65% 46.37B
DEXCOM, INC. Stock DexCom, Inc.
-6.69% 46.05B
HOYA CORPORATION Stock Hoya Corporation
+7.97% 42.54B
ZIMMER BIOMET HOLDINGS, INC. Stock Zimmer Biomet Holdings, Inc.
-6.87% 23.32B
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
-10.63% 22.92B
STERIS PLC Stock STERIS plc
+3.18% 22.44B
Other Medical Equipment, Supplies & Distribution
  1. Stock Market
  2. Equities
  3. MTD Stock
  4. Financials Mettler-Toledo International, Inc.